EN HU

HUN-REN-DE Sejtbiológiai és Jelátvitel Kutatócsoport

HUN-REN-DE Sejtbiológiai és Jelátvitel Kutatócsoport
HUN-REN-DE Sejtbiológiai és Jelátvitel Kutatócsoport
Uploaded publications:
45
Publications in DEA:
45
OA:
34
Date range:
2022-2025
2025
1.
Gyöngyösi, A., Korpos, É., Kállai, J., Lányi, Á.: A mieloid eredetű szuppresszor sejtek szerepe a tumor mikrokörnyezetben, terápiás lehetőségek.
Immunol. Szle. 17 (1), 34-43, 2025.
2.
Nagy, L., Nagy, G., Juhász, T., Fillér, C., Szűcs, G., Szekanecz, Z., Vereb, G., Antal-Szalmás, P., Szöőr, Á.: Comparative Evaluation of Bleomycin- and Collagen-V-Induced Models of Systemic Sclerosis: insights into Fibrosis and Autoimmunity for Translational Research.
Int. J. Mol. Sci. 26 (6), 1-15, (article identifier: 2618), 2025.
Journal metrics:
Q2 Catalysis (2024)
Q1 Computer Science Applications (2024)
Q1 Inorganic Chemistry (2024)
Q1 Medicine (miscellaneous) (2024)
Q2 Molecular Biology (2024)
D1 Organic Chemistry (2024)
Q1 Physical and Theoretical Chemistry (2024)
D1 Spectroscopy (2024)
3.
Kemenes, G., Rebenku, I., Bajdik, B., Vereb, G., Takács, L.: Correlation of Multimodal Clinical Imaging With the Whole-Slide- and Superresolution-Based Immunohistological Structure of the Corneal Limbal Stroma.
Invest. Ophthalmol. Vis. Sci. 66 (9), 1-13, (article identifier: 54), 2025.
Journal metrics:
Q2 Cellular and Molecular Neuroscience (2024)
Q1 Ophthalmology (2024)
Q1 Sensory Systems (2024)
4.
Pourjamal, N., Le Joncour, V., Vereb, G., Honkamaki, C., Isola, J., Leyton, J. V., Laakkonen, P., Joensuu, H., Barok, M.: Disitamab vedotin in preclinical models of HER2-positive breast and gastric cancers resistant to trastuzumab emtansine and trastuzumab deruxtecan.
Translational Oncology. 53, 1-9, (article identifier: 102284), 2025.
Journal metrics:
Q2 Cancer Research (2024)
Q1 Oncology (2024)
5.
Ujlaky-Nagy, L., Szöllősi, J., Vereb, G.: EGFR-HER2 Transactivation Viewed in Space and Time Through the Versatile Spectacles of Imaging Cytometry - Implications for Targeted Therapy.
Cytom. Part A. 107 (3), 187-202, 2025.
Journal metrics:
Q3 Cell Biology (2024)
Q1 Histology (2024)
Q1 Pathology and Forensic Medicine (2024)
6.
Nagyné Szabó, Á. T., Tóth, G., Szatmári, T., Mocsár, G., Rebenku, I., Szöllősi, J., Nagy, P.: Local ligand concentration gradients induced by the plasma membrane.
iScience. 28 (7), 1-12, (article identifier: 112954), 2025.
Journal metrics:
D1 Multidisciplinary (2024)
7.
Borrego, J., Mészáros, B., Szántó, G. T., Teshome, R. T., Korpos, É., Varga, Z., Papp, F.: Modulators of the Human Voltage-Gated Proton Channel Hv1.
Pharmaceuticals. 18 (10), 1-15, (article identifier: 1480), 2025.
Journal metrics:
Q1 Drug Discovery (2024)
Q2 Molecular Medicine (2024)
Q1 Pharmaceutical Science (2024)
8.
Horváth, D., Pénzes, Z., Molnár, P., Rebenku, I., Vereb, G., Szántó, M., Muzsai, S., Szegedi, A., Dajnoki, Z., Pázmándi, K. L., Fekete, T., Bácsi, A., Szöllősi, A. G.: Natriuretic peptides modulate monocyte-derived Langerhans cell differentiation and promote a migratory phenotype.
Front. Immunol. 16, 1-14, (article identifier: 1593141), 2025.
Journal metrics:
Q1 Immunology (2024)
Q1 Immunology and Allergy (2024)
9.
Lendvai, A., Béke, G., Hollósi, E., Braun, N., Theek, C., Kállai, J., Lányi, Á., Becker, M., Völker, J. M., Schulze zur Wiesche, E., Bácsi, A., Bíró, T., Mihály, J.: N,N-Dimethylglycine Sodium Salt as a Multifaceted Skin Agent Targeting Skin Inflammation, Microvascular Biology, and Senescence-Driven Hair Loss.
J. Invest. Dermatol. 145 (11), e44, 2025.
10.
Lendvai, A., Béke, G., Hollósi, E., Völker, J. M., Schulze zur Wiesche, E., Kállai, J., Lányi, Á., Bácsi, A., Bíró, T., Mihály, J.: N,N-Dimethylglycine sodium salt exerts anti-aging effects in human dermal papilla senescence models in vitro.
Immunol. Szle. 17 (3), 35, 2025.
11.
Bíró, T., Béke, G., Lendvai, A., Hollósi, E., Völker, J. M., Schulze zur Wiesche, E., Kállai, J., Lányi, Á., Bácsi, A., Mihály, J.: N,N-Dimethylglycine sodium salt exerts marked anti-aging effects in various human dermal papilla senescence models in vitro.
J. Invest. Dermatol. 145 (12), S348, 2025.
12.
Juhász, P., Bohus, P., Sipos, A., Curtin, N., Méhes, G., Bai, P.: Oxidative stress and PARP activation in the lungs is an early event in COVID-19 pneumonia.
Free Radic. Biol. Med. 237, 530-541, 2025.
Journal metrics:
D1 Biochemistry (2024)
D1 Physiology (medical) (2024)
13.
Gyuris, K., Domingos, G. J., Korpos, É., Mészáros, B., Piga, M., Zidar, N., Varga, Z.: Role of the hHv1 proton channel in vascular smooth muscle cells.
Biophys. J. 124 (3), 294a, 2025.
14.
Gergely, B., Vereb, M. A., Rebenku, I., Vereb, G., Szöőr, Á.: Targeting HER2-Positive Solid Tumors with CAR NK Cells: CD44 Expression Is a Critical Modulator of HER2-Specific CAR NK Cell Efficacy.
Cancers. 17 (5), 1-17, (article identifier: 731), 2025.
Journal metrics:
Q2 Cancer Research (2024)
Q1 Oncology (2024)
15.
Bede, Á. M., Váróczy, C., Polgár, Z., Fazekas, G., Hegedűs, C., Kókai, E., Kovács, K., Virág, L.: The autophagy inhibitor bafilomycin inhibits antibody-dependent natural killer cell-mediated killing of breast carcinoma cells.
Int. J. Mol. Sci. 26, 1-19, (article identifier: 6273), 2025.
Journal metrics:
Q2 Catalysis (2024)
Q1 Computer Science Applications (2024)
Q1 Inorganic Chemistry (2024)
Q1 Medicine (miscellaneous) (2024)
Q2 Molecular Biology (2024)
D1 Organic Chemistry (2024)
Q1 Physical and Theoretical Chemistry (2024)
D1 Spectroscopy (2024)
16.
Sipos, A., Kerekes, É., Szeőcs, D., Szarvas, F., Schwarcz, S., Tóth, E., Ujlaki, G., Mikó, E., Bai, P.: Ursodeoxycholic acid prompts glycolytic dominance, reductive stress and epithelial-to-mesenchymal transition in ovarian cancer cells through NRF2 activation.
Cell Death Discov. 11 (1), 1-10, (article identifier: 134), 2025.
Journal metrics:
Q1 Cancer Research (2024)
Q1 Cell Biology (2024)
Q1 Cellular and Molecular Neuroscience (2024)
Q1 Immunology (2024)
2024
17.
Kovács, P., Schwarcz, S., Nyerges, P., Bíró, T. I., Ujlaki, G., Bai, P., Mikó, E.: Anticarcinogenic effects of ursodeoxycholic acid in pancreatic adenocarcinoma cell models.
Front. Cell. Dev. Biol. 12, 1-14, (article identifier: 1487685), 2024.
Journal metrics:
Q1 Cell Biology
Q1 Developmental Biology
18.
Szeőcs, D., Vida, B., Petővári, G., Póliska, S., Janka, E. A., Sipos, A., Uray, K., Sebestyén, A., Krasznai, Z. T., Bai, P.: Cell-free ascites from ovarian cancer patients induces Warburg metabolism and cell proliferation through TGFbeta-ERK signalling.
GeroScience. 46 (4), 3581-3597, 2024.
Journal metrics:
Q1 Aging
Q1 Cardiology and Cardiovascular Medicine
D1 Complementary and Alternative Medicine
Q1 Geriatrics and Gerontology
D1 Veterinary (miscellaneous)
19.
Kállai, J., Gindele, R., Pénzes-Daku, K., Balogh, G., Kissné Bogáti, R., Bécsi, B., Katona, É., Oláh, Z., Ilonczai, P., Boda, Z., Róna-Tas, Á., Nemes, L., Marton, I., Bereczky, Z.: Clinical and Molecular Characterization of Nine Novel Antithrombin Mutations.
Int. J. Mol. Sci. 25 (5), 1-19, (article identifier: 2893), 2024.
Journal metrics:
Q2 Catalysis
Q1 Computer Science Applications
Q1 Inorganic Chemistry
Q1 Medicine (miscellaneous)
Q2 Molecular Biology
D1 Organic Chemistry
Q1 Physical and Theoretical Chemistry
D1 Spectroscopy
20.
Piga, M., Varga, Z., Fehér, Á., Papp, F., Korpos, É., Bangera, K. C., Frlan, R., Ilas, J., Dernovsek, J., Tomasic, T., Zidar, N.: Correction to "Identification of a Novel Structural Class of HV1 Inhibitors by Structure-Based Virtual Screening".
J. Chem Inf. Model. 64 (24), 9651, 2024.
21.
Schwarcz, S., Nyerges, P., Bíró, T. I., Janka, E. A., Bai, P., Mikó, E.: Cytostatic Bacterial Metabolites Interfere with 5-Fluorouracil, Doxorubicin and Paclitaxel Efficiency in 4T1 Breast Cancer Cells.
Molecules. 29 (13), 1-16, (article identifier: 3073), 2024.
Journal metrics:
Q1 Analytical Chemistry
Q1 Chemistry (miscellaneous)
Q2 Drug Discovery
Q2 Medicine (miscellaneous)
Q2 Molecular Medicine
Q1 Organic Chemistry
Q1 Pharmaceutical Science
Q1 Physical and Theoretical Chemistry
22.
Ujlaky-Nagy, L., Szöllősi, J., Vereb, G.: Disrupting EGFR-HER2 Transactivation by Pertuzumab in HER2-Positive Cancer: quantitative Analysis Reveals EGFR Signal Input as Potential Predictor of Therapeutic Outcome.
Int. J. Mol. Sci. 25 (11), 1-20, (article identifier: 5978), 2024.
Journal metrics:
Q2 Catalysis
Q1 Computer Science Applications
Q1 Inorganic Chemistry
Q1 Medicine (miscellaneous)
Q2 Molecular Biology
D1 Organic Chemistry
Q1 Physical and Theoretical Chemistry
D1 Spectroscopy
23.
Kolostyák, Z., Bojcsuk, D., Baksa, V., Máthéné Szigeti, Z., Bene, K., Czimmerer, Z., Botó, P., Fadel, L., Póliska, S., Halász, L., Tzerpos, P., Berger, W. K., Villabona-Rueda, A., Varga, Z., Kovács, T., Patsalos, A., Pap, A., Vámosi, G., Bai, P., Dezső, B., Spite, M., D'Alessio,, F. R., Szatmári, I., Nagy, L.: EGR2 is an epigenomic regulator of phagocytosis and antifungal immunity in alveolar macrophages.
JCI Insight. 9 (17), 1-21, (article identifier: 164009), 2024.
Journal metrics:
D1 Medicine (miscellaneous)
24.
Mikó, E., Sipos, A., Tóth, E., Lehoczki, A., Fekete, M., Sebő, É., Kardos, G., Bai, P.: Guideline for designing microbiome studies in neoplastic diseases.
GeroScience. 46 (5), 4037-4057, 2024.
Journal metrics:
Q1 Aging
Q1 Cardiology and Cardiovascular Medicine
D1 Complementary and Alternative Medicine
Q1 Geriatrics and Gerontology
D1 Veterinary (miscellaneous)
25.
Piga, M., Varga, Z., Fehér, Á., Papp, F., Korpos, É., Bangera, K. C., Frlan, R., Ilas, J., Dernovsek, J., Tomasic, T., Zidar, N.: Identification of a Novel Structural Class of Hv1 Inhibitors by Structure-Based Virtual Screening.
J. Chem Inf. Model. 64 (12), 4850-4862, 2024.
Journal metrics:
Q1 Chemical Engineering (miscellaneous)
Q1 Chemistry (miscellaneous)
Q1 Computer Science Applications
D1 Library and Information Sciences
DEENK University of Debrecen
© 2012 University of Debrecen